Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Pfizer-Allergan deal: what next for contract manufacturers?

25-Nov-2015 - As CMOs wait to see the short-term fallout of the Pfizer-Allergan deal, an M&A expert says contract manufacturing will follow the CRO industry in embracing strategic alliances and consolidation....

CRL buys German mouse model CRO for €34m

24-Nov-2015 - Charles River has acquired German preclinical CRO Oncotest GmbH in a €34m ($36m) cash deal.

Recipharm reports 55% sales growth; North America next step in M&A strategy

05-Nov-2015 - Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.

Video Q&A

Niche tech and biologics the new drivers for CMO consolidation, says PBOA

05-Nov-2015 - CMO consolidation strategy has shifted from building scale and adding geographies towards niche technologies and biologics, according to the founder of trade association PBOA.

'Highest ever' cancellation rate impairs Parexel's Q1 FY16 results

02-Nov-2015 - Parexel has lowered its revenue guidance for the year following cancellations worth $305m in its first quarter FY2016.

CROs engaging in a ‘war on talent’, Quintiles CEO says

30-Oct-2015 - The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by...

Pfizer-Allergan megamerger report prompts speculation about fallout for CROs

29-Oct-2015 - Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think...

Covance toxicology capacity use still suboptimal despite improvements

28-Oct-2015 - Covance has reported capacity use at its preclinical toxicology business is in the 70% range, meaning it is still well below optimal levels despite recent improvements.

CPhI Worldwide 2015

Rush to acquire ex-pharma sites means survival of the biggest for CMOs

22-Oct-2015 - As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say...

Indian CMO latest acquisition in Recipharm's aggressive growth push

20-Oct-2015 - An agreement to buy Indian CMO Nitin boosts Recipharm’s presence in emerging markets and plays into its aggressive growth strategy, the firm says.

Greatbatch: $1.7bn acq 'transfromative' in the medical device space

22-Sep-2015 - Standard & Poor has assigned a ‘stable’ rating to Greatbatch after the contract manufacturer secured $1.5bn to buy fellow medical devicemaker Lake Region Medical.

Parexel: M&A likely to continue despite $200m stock repurchase plan

15-Sep-2015 - Parexel could repurchase up to $200m (€175m) of its stock in FY 2016, but one analyst says the firm remains committed to it M&A strategy.

Mid-size CRO consolidation: Chiltern completes Theorem deal

14-Sep-2015 - Chiltern has completed its acquisition of Theorem, making it the self-declared “largest mid-sized” CRO.

SynteractHCR: ‘Customers like working with a mid-sized CRO’

11-Sep-2015 - Tech investment, flexibility and responsiveness have led to double-digit growth in customers, mid-sized CRO SynteractHCR says.

Concept Life Sciences buys UK toxicology biz

18-Aug-2015 - British CRO Concept Life Sciences has bought toxicology business CXR Biosciences, its fourth acquisition since it formed in July 2014.

CMO use on the up, low margins ahead

12-Aug-2015 - Contract manufacturing will rise over the next five years as drugmakers feel the pressure to reduce supply chain time, and choose to focus on in-house R&D rather than conduct their...

iCardiac acquires clinical trials division of nSpire Health

07-Aug-2015 - Cardiac safety assessment service provider iCardiac Technologies has added respiratory and ePRO services to its offerings through the acquisition of the clinical trials division of nSpire Health.


Parexel to lay off up to 125 transferred GSK employees

03-Aug-2015 - Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last...

BioClinica acquires patient recruitment, retention firm MediciGroup

07-Jul-2015 - Specialty trials services and tech provider BioClinica has acquired the patient recruitment and retention firm, MediciGroup. Financial terms of the deal were not disclosed. 

Preclinical consolidation: MSI firm Protea buys CRO vivoPharm

08-Apr-2015 - Molecular imaging company Protea Biosciences has acquired CRO vivoPharm in the latest instance of consolidation in the preclinical sector.

Exclusive interview

Rise in outsourcing to lead to further CMO consolidation, DPx CEO says

18-Mar-2015 - The CMO (contract manufacturing organization) industry is ripe for consolidation as the rise in outsourcing continues and clients look to simplify their supply chains, DPx CEO James Mullen told

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

Exclusive interview

It's not the size... CRO Simbec-Orion on why it can compete with Quintiles

05-Feb-2015 - Being a drug developer not just a service provider differentiates Simbec-Orion from the Big CROs according to CEO Ronald Openshaw, whose firm signed two strategic partnerships last week.

Covance's LabCorp distraction will drive opportunities for CRL, says analyst

23-Jan-2015 - Investment firm William Blair has upgraded preclinical CRO Charles River Laboratories to ‘outperform’ based on strong toxicology demand and the pending acquisition of Covance.


Consolidation among small CROs could drive up prices, says analyst

21-Jan-2015 - Competition among small CROs kept prices steady in 2014 despite higher sponsor R&D spending and greater outsourcing penetration, according to a Citi Research survey.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...